Brief: Collplant To Receive $10 Mln From Abbvie In Accordance With Its Regenerative Dermal Filler Product Collaboration Agreement

Collplant Biotechnologies

26/06/2023 13:27

June 26 (Reuters) - Collplant Biotechnologies Ltd
 CPTG.F :
    * COLLPLANT BIOTECHNOLOGIES- IN 2021, GRANTED ABBVIE
EXCLUSIVE
LICENSE TO USE ITS RHCOLLAGEN TECHNOLOGY IN COMBINATION WITH
ABBVIE'S PROPRIETARY TECHNOLOGIES (ADDS DROPPED WORDS 'IN 2021')
    * COLLPLANT ACHIEVES MILESTONE AND TO RECEIVE $10 MILLION
FROM
ABBVIE IN ACCORDANCE WITH ITS REGENERATIVE DERMAL FILLER PRODUCT
COLLABORATION AGREEMENT